CC
GILD icon

Chicago Capital’s Gilead Sciences GILD Stock Holding History

Chicago Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
4,332
+240
+6% +$31.6K 0.01% 262
2026
Q1 		$570K Hold
4,092
– – 0.02% 252
2025
Q4 		$502K Buy
4,092
+34
+0.8% +$4.13K 0.01% 263
2025
Q3 		$450K Sell
4,058
-63
-2% -$7.16K 0.01% 254
2025
Q2 		$457K Buy
4,121
+113
+3% +$12K 0.01% 261
2025
Q1 		$449K Hold
4,008
– – 0.01% 248
2024
Q4 		$370K Hold
4,008
– – 0.01% 248
2024
Q3 		$336K Sell
4,008
-66
-2% -$5.04K 0.01% 253
2024
Q2 		$280K Sell
4,074
-220
-5% -$14.7K 0.01% 273
2024
Q1 		$315K Sell
4,294
-300
-7% -$23.1K 0.01% 249
2023
Q4 		$372K Buy
4,594
+300
+7% +$23.3K 0.01% 218
2023
Q3 		$322K Hold
4,294
– – 0.02% 183
2023
Q2 		$331K Hold
4,294
– – 0.01% 183
2023
Q1 		$356K Hold
4,294
– – 0.02% 177
2022
Q4 		$369K Buy
4,294
+570
+15% +$45.1K 0.02% 176
2022
Q3 		$230K Hold
3,724
– – 0.01% 215
2022
Q2 		$230K Sell
3,724
-350
-9% -$21.7K 0.01% 218
2022
Q1 		$242K Hold
4,074
– – 0.01% 232
2021
Q4 		$296K Hold
4,074
– – 0.01% 214
2021
Q3 		$285K Hold
4,074
– – 0.01% 216
2021
Q2 		$281K Hold
4,074
– – 0.01% 212
2021
Q1 		$263K Hold
4,074
– – 0.01% 216
2020
Q4 		$237K Sell
4,074
-18
-0.4% -$1.09K 0.01% 217
2020
Q3 		$259K Hold
4,092
– – 0.01% 204
2020
Q2 		$315K Buy
4,092
+250
+7% +$19.2K 0.02% 183
2020
Q1 		$287K Hold
3,842
– – 0.02% 166
2019
Q4 		$250K Sell
3,842
-451
-11% -$29.4K 0.02% 197
2019
Q3 		$272K Buy
4,293
+204
+5% +$13.3K 0.02% 191
2019
Q2 		$276K Sell
4,089
-183
-4% -$12K 0.02% 195
2019
Q1 		$278K Buy
+4,272
New +$284K 0.02% 187

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Chicago Capital's GILD Position: Q2 2026 in Review

Chicago Capital increased its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, buying an estimated $31.6K and bringing the position to 4,332 shares worth $547K. The position accounts for 0.01% of the portfolio, ranked #262.

Chicago Capital first reported a position in GILD in Q1 2019 and has held it in 30 quarters since. The position peaked at $570K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chicago Capital held 4,332 shares of Gilead Sciences worth $547K as of Q2 2026.
  • Chicago Capital bought 240 Gilead Sciences shares in Q2 2026, an estimated $31.6K.
  • Gilead Sciences made up 0.01% of Chicago Capital's portfolio in Q2 2026, its #262 holding.
  • Chicago Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 30 quarters since.
  • Chicago Capital's Gilead Sciences position peaked at $570K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.